Abstract
Major aims of insulin chemistry are the large-scale production of the hormone for the treatment of diabetes mellitus as well as laboratory-scale syntheses of analogs for structure-function studies, of radioactive tracers, and of “tailormade” special derivatives. Further, one should include the detection and isolation of new native insulins and related compounds. The total synthesis, accomplished 25 years ago by the groups of ZAHN (MEIENHOFER et al. 1963), KATSOYANNIS (1964), and in China marked the advent of a new era in pep tide and protein chemistry. Remarkable progress has since been achieved through refinement of synthetic and semisynthetic procedures, the advances in recombinant DNA techniques, and high pressure liquid chromatography (HPLC).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ambrosius D, Bala-Mohan S, Behrendt C, Schäfer K, Schüttler A, Brandenburg D (1987) New photoreactive derivatives of insulin for affinity-labelling of the insulin receptor. In: Theodoropoulos D (ed) Peptides 1986. De Gruyter, New York, pp 521–523
Assoian RK, Thomas NE, Kaiser ET, Tager HS (1982) [LeuB24]Insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs. Proc Natl Acad Sci USA 79:5147–5151
Bahrami S, Zahn H, Brandenburg D, Machulla H-J, Dutschka K (1980) [B1-125I-Desaminotyrosine] insulin — a novel homogeneous insulin tracer. Radiochem Radioanal Lett 45:221–226
Brandenburg D, Saunders D (1985) Preparation and characterization of photoactivatable insulin analogues. In: De Pirro R, Lauro R (eds) Insulin receptors. Field Educational Italia, ACTA MEDICA, Rome, pp 20–32 (Handbook on receptor research)
Brandenburg D, Wollmer A (1980) (eds) Insulin: chemistry, structure and function of insulin and related hormones. De Gruyter, New York
Brandenburg D, Gattner H-G, Schermutzki W, Schüttler A, Uschkoreit J, Weimann J, Wollmer A (1977) Crosslinked insulins: preparation, properties, and applications. In: Friedman M (ed) Protein crosslinking: biochemical and molecular aspects. Plenum, New York, pp 261–282 (Advances in experimental medicine and biology, vol 86 A.)
Brandenburg D, Saunders D, Schüttler A (1983) Pancreatic hormones. In: Jones JH (senior reporter) Amino-acids, peptides and proteins, vol 14. Specialist periodical reports. Royal Society of Chemistry, London, pp 461-476
Brange J (1987) Galenics of insulin. The physico-chemical and pharmaceutical aspects of insulin and insulin preparations. Springer, Berlin Heidelberg New York Tokyo
Brange J, Ribel U, Hansen JF, Dodson G, Hansen MT, Havelund S, Melberg SG, Noms F, Noms K, Snel L, Sørensen AR, Voigt HO (1988) Monomeric insulins obtained by protein engineering and their medical implications. Nature 333:679–682
Breddam K, Johansen JT (1984) Semisynthesis of human insulin utilizing chemically modified carboxypeptidase Y. Carlsberg Res Commun 49:463–472
Büllesbach EE (1982) Semisynthesis of a shortened open-chain proinsulin. Tetrahedron Lett 23:1877–1880
Büllesbach EE, Brandenburg D (1981) Synthesis of insulin analogues. In: Keck K, Erb P (eds) Basic and clinical aspects of immunity to insulin. De Gruyter, New York, pp 395–419
Burke GT, Schwartz G, Katsoyannis PG (1984) Nature of the B10 ammo acid residue. Requirements for high biological activity of insulin. Int J Pept Protein Res 23:394–401
Cao Q-P, Geiger R, Langner D, Geisen K (1986) Biological activity in vivo of insulin analogues modified in the N-terminal region of the B-chain. Biol Chem Hoppe Seyler 367:135–140
Cao Q-P, Zhang Y-S, Geiger R (1988) Comparison of reaction rates in trypsin-catalysed transamidation of porcine insulin and its B29-arginme analogue. Biol Chem Hoppe-Seyler 369:283–287
Casaretto M, Spoden M, Diaconescu C, Gattner H-G, Zahn H, Brandenburg D, Wollmer A (1987) Shortened insulin with enhanced in vitro potency. Biol Chem Hoppe-Seyler 368:709–716
Casaretto R (1986) Merrifieldsynthese von [Ala12]-und [Ile12]Insulin-B-Ketten und Kombination mit natürlicher A-Kette. Dissertation, RWTH Aachen
Cascieri MA, Chicchi GG, Applebaum J, Hayes NS, Green BG, Bayne ML (1988) Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor. Biochemistry 27:3229–3233
Chan SJ, Seino S, Gruppuso PA, Schwartz R, Steiner DF (1987) A mutation in the B chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinemia. Proc Natl Acad Sci USA 84:2194–2197
Chu Y-C, Burke GT, Chanley JD, Katsoyannis PG (1987a) Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 2. [21-Asparagine diethylamide-A] insulin. Biochemistry 26:6972–6975
Chu Y-C, Wang R-Y, Burke GT, Chanley JD, Katsoyannis PG (1987b) Possible involvement of the A20–A21 peptide bond in the expression of the biological activity of insulin. 1. [21-Desasparagine, 20-cysteinamide-A]insulin and [21-desasparagine, 20cysteine isopropylamide-A]-insulin. Biochemistry 26:6966–6971
Chu Y-C, Wang R-Y, Burke GT, Chanley JD, Katsoyannis PG (1987c) Possible involvement of the A20–A21 peptide bond in the expression of the biological activity of insulin. 3. [21-Desasparagine, 20-cysteine-2, 2, 2-trifluorethylamide-A]insulin. Biochemistry 26:6975–6979
Conlon JM, Dafgård E, Falkmer S, Thim L (1986) The primary structure of ratfish insulin reveals an unusual mode of proinsulin processing. FEBS Lett 208:445–450
Cutfield JF, Cutfield SM, Carne A, Emdin SO, Falkmer S (1986a) The isolation, purification and amino-acid sequence of insulin from the teleost fish Cottus scorpius (daddy sculpin). Eur J Biochem 158:117–123
Cutfield SM, Dodson GG, Ronco N, Cutfield JF (1986b) Preparation and activity of nitrated insulin dimer. Int J Pept Protein Res 27:335–343
Davies JG, Offord RE (1985) The preparation of tritiated insulin specifically labelled by semisynthesis at glycine-Al. Biochem J 231:389–392
Davies JG, Offord RE (1988) The chemical characterization of the radioactive products derived from [[3H]PheBl] insulin in the circulation of the rat. Biochem J 250:389–393
Davies JG, Muir AV, Offord RE (1986) Identification of some cleavage sites of insulin by insulin proteinase. Biochem J 240:609–612
Davies JG, Rose K, Bradshaw CG, Offord RE (1987) Enzymatic semisynthesis of insulin specifically labelled with tritium at position B-30. Protein Engineering 1:407–411
Dawson DB, Varandani PT (1987) Characterization and application of monoclonal antibodies directed to separate epitopes of glutathione-insulin transhydrogenase. Biochim Biophys Acta 923:389–400
De Gasparo M, Faupel M (1986) Chromatographic characterization of adult and foetal rat insulin. J Chromatogr 357:139–146
Dodson G, Glusker JP, Sayre D (eds) (1981) Structural studies on molecules of biological interest. A volume in honour of Prof. Dorothy Hodgkin. Clarendon, Oxford
Drewes SE, Magojo HEM, Gliemann J (1983) (N-Methylpyridinium) insulins. Modification at the Al 9-and B16-tyrosines. Hoppe-Seyler’s Z Physiol Chem 364:461–468
Duckworth WC, Hamel FG, Peavy DE, Liepnieks JJ, Ryan MP, Hermodson MA, Frank BH (1988) Degradation products of insulin generated by hepatocytes and by insulin protease. J Biol Chem 263:1826–1833
Evans TK, Litthauer D, Oelofsen W (1988) Purification and primary structure of ostrich insulin. Int J Pept Protein Res 31:454–462
Fan L, Cui DF, Zhang YS (1985) Enzymatic synthesis of deshexapeptide insulin in the presence of high concentration of 1, 4-butandiol. Chin Biochem J 1:33–36
Ferderigos N, Burke GT, Kitagawa K, Katsoyannis PG (1983) The effect of modifications of the A5 and Al 9 amino acid residues on the biological activity of insulin. [Leu5-A] and [Phel9-A] sheep insulins. J Protein Chem 2:147–170
Finn FM, Titus G, Hofmann K (1984a) Ligands for insulin receptor isolation. Biochemistry 23:2554–2558
Finn FM, Titus G, Horstman D, Hofmann K (1984b) Avidin-biotin affinity chromatography: application to the isolation of human placental insulin receptor. Proc Natl Acad Sci USA 81:7328–7332
Fischel-Ghodsian F, Brown L, Mathiowitz E, Brandenburg D, Langer R (1988) Enzymati-cally controlled drug delivery. Proc Natl Acad Sci USA 85:2403–2406
Fischer WH, Saunders D, Brandenburg D, Wollmer A, Zahn H (1985a) A shortened insulin with full in vitro potency. Biol Chem Hoppe-Seyler 366: 521–525
Fischer WH, Saunders DJ, Zahn H, Wollmer A (1985b) Synthesis and properties of a disulphide-bridged insulin dimer. In: Deber CM, Hruby VJ, Kopple KD (eds) Pep-tides, structure and function. Pierce Chem Comp, Rockford, pp 301–304
Fischer WH, Saunders D, Brandenburg D, Diaconescu C, Wollmer A, Dodson G, De Meyts P, Zahn H (1986) Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin. Biol Chem Hoppe-Seyler 367:999–1006
Frank BH, Chance RE (1983) Two routes for producing human insulin utilizing recombinant DNA technology. Münch Med Wochenschr 125 [Suppl 1]:14–20
Galpin IJ, Hancock G, Kenner GW, Morgan BA (1983) The synthesis of an insulin active site analogue. Tetrahedron 39:149–158
Gammeltoft S (1984) Insulin receptors: binding kinetics and structure-function relationship of insulin. Physiol Rev 64:1321–1378
Gattner H-G, Sommer M-T (1989) Enzymatic preparation of hydrazides of insulin derivatives as intermediates for chemical syntheses In: König WA, Voelter W (eds) Chemistry of peptides and proteins, vol 4. Attempto, Tübingen, pp 111–117
Gattner H-G, Danho W, Knorr R, Naithani VK, Zahn H (1981) Trypsin catalyzed peptide synthesis: modification of the B-chain C-terminal region of insulin. In: Brunfeldt K (ed) Peptides 1980. Scriptor, Copenhagen, pp 372–377
Gattner H-G, Danho W, Knorr R, Zahn H (1982) Trypsin catalyzed peptide synthesis: modification of the B-chain C-terminal region of insulin. In: Voelter W, Wünsch E, Ovchinnikov YU, Ivanov V (eds) Chemistry of peptides and proteins, vol 1. De Gruyter, New York, pp 319–325
Geiger R, Geisen K, Summ H-D (1982) Austausch von A1-Glycin in Rinderinsulin gegen L-und D-Tryptophan. Hoppe-Seyler’s Z Physiol Chem 363:1231–1239
Grant KI, von Holt C (1987) Improved preparation of semisynthetic PheB1-tritiated insulin. Biol Chem Hoppe-Seyler 368:239–248
Grau U (1985a) Fingerprint analysis of insulin and proinsulins. Diabetes 34:1174–1180
Grau U (1985b) Chemical stability of insulin in a delivery system environment. Diabetologia 28:458–463
Grau U, Saudek CD (1987) Stable insulin preparation for implanted insulin pumps. Laboratory and animal trials. Diabetes 36:1453–1459
Halban PA, Rhodes CJ, Shoelson SE (1986) High-performance liquid chromatography (HPLC): a rapid, flexible and sensitive method for separating islet proinsulin and insulin. Diabetologia 29:893–896
Halldén G, Gafvelin G, Mutt V, Jörnvall H (1986) Characterization of cat insulin. Arch Biochem Biophys 247:20–27
Hamel FG, Peavy DE, Ryan MP, Duckworth WC (1987) HPLC analysis of insulin degradation products from isolated hepatocytes. Effects of inhibitors suggest in-tracellular and extracellular pathways. Diabetes 36:702–708
Haneda M, Chan SJ, Kwok SCM, Rubenstein AH, Steiner DF (1983) Studies on mutant human insulin genes: identification and sequence analysis of a gene encoding [SerB24]insulin. Proc Natl Acad Sci USA 80:6366–6370
Heidenreich KA, Yip CC, Frank BH, Olefsky JM (1985) The preparation and characterization of mono-iodinated photoreactive analogs of insulin. Biochem Biophys Res Commun 126:1138–1145
Hellfritzsch M, Christensen EI, Sonne O (1986) Luminal uptake and intracellular transport of insulin in renal proximal tubules. Kidney Int 29:983–988
Hofmann K, Zhang WJ, Romovacek H, Finn FM, Bothner-By AA, Mishra PK (1984) Syntheses of biotinylated and dethiobiotinylated insulins. Biochemistry 23:2547–2553
Hofmann K, Romovacek H, Titus G, Ridge K, Raffensperger JA, Finn FM (1987) The rat liver insulin receptor. Biochemistry 26:7384–7390
Hua Q-X, Qian Y-Q, Tsou C-L (1984) The interaction of the S-thiomethyl insulin A and B chains in solution. Biochim Biophys Acta 789:234–240
Humburg E, Gattner H-G, Zahn H, Brandenburg D Synthesis and characterization of sulfated insulins (in preparation)
Inouye K, Watanabe K, Kanaya T, Tochino Y, Kobayashi M, Haneda M, Shigeta Y (1985) Insulin semisynthesis with N’B1-FMOC-DOI as intermediate. In: Izumiya HN (ed) Peptide chemistry 1984. Protein Research Foundation, Osaka, pp 193–198
Jakubke H-D (1987) Enzymatic peptide synthesis. In: Udenfried S, Meienhofer J (eds) The peptides: analysis, synthesis, biology, vol 9. Special methods in peptide synthesis, part C. Academic Press, New York, pp 103–165
Johnson IS’ (1983) Human insulin from recombinant DNA technology. Science 219:632–637
Jones RML, Rose K, Offord RE (1987) Semisynthetic human [[3H2]Phel]proinsulin. Biochem J 247:785–788
Joshi S, Burke GT, Katsoyannis PG (1985a) Synthesis of an insulin-like compound consisting of the A chain of insulin and a B chain corresponding to the B domain of human insulin-like growth factor I. Biochemistry 24:4208–4214
Joshi S, Ogawa H, Burke GT, Tseng L Y-H, Rechler MM, Katsoyannis PG (1985b) Structural features involved in the biological activity of insulin and the insulin-like growth factors: A27 insulin/B IGF-L Biochem Biophys Res Commun 133:423–429
Katsoyannis PG (1964) The synthesis of the insulin chains and their combination to biologically active material. Diabetes 13:339–348
Katsoyannis PG, Schwartz GP, Burke GT, Joshi S (1987) Insulin-like growth factors: structure-activity relationships. In: Theodoropoulos D (ed) Peptides 1986. De Gruyter, New York, pp 43–60
Keck K, Erb P (eds) (1981) Basic and clinical aspects of immunity to insulin. De Gruyter, New York
King GL, Kahn CR, Samuels B, Danho W, Büllesbach EE, Gattner HG (1982) Synthesis and characterization of molecular hybrids of insulin and insulin-like growth factor I. J Biol Chem 257:10869–10873
Kitagawa K, Ogawa H, Burke GT, Chanley JD, Katsoyannis PG (1984a) Critical role of the A2 amino acid residue in the biological activity of insulin: [2-Glycine-A]-and [2-Alanine-A]insulins. Biochemistry 23:1405–1413
Kitagawa K, Ogawa H, Burke GT, Chanley JD, Katsoyannis PG (1984b) Interaction between the A2 and A19 amino acid residues is of critical importance for high biological activity in insulin: [19-Leucine-A]insulin. Biochemistry 23:4444–4448
Knorr R, Danho W, Büllesbach EE, Gattner H-G, Zahn H, King GL, Kahn CR (1982) [B22-D-Arginine]Insulin: synthesis and biological properties. Hoppe Seyler’s Z Physiol Chem 363:1449–1460
Knorr R, Danho W, Büllesbach EE, Gattner H-G, Zahn H, King GL, Kahn CR (1983) [B17-D-Leucine]Insulin and [B17-Norleucine]Insulin: synthesis and biological properties. Hoppe-Seyler’s Z Physiol Chem 364:1615–1626
Knutson VP (1987) The covalent tagging of the cell surface insulin receptor in intact cells with the generation of an insulin-free, functional receptor. J Biol Chem 262:2374–2383
Kobayashi M, Ohgaku S, Iwasaki M, Maegawa H, Shigeta Y, Inouye K (1982a) Characterization of [LeuB24]-and [LeuB25]-insulin analogues. Biochem J 206:597–603
Kobayashi M, Ohgaku S, Iwasaki M, Maegawa H, Shigeta Y, Inouye K (1982b) Supernormal insulin: [D-PheB24]-insulin with increased affinity for insulin receptors. Biochem Biophys Res Commun 107:329–336
Kubiak T, Cowburn D (1986a) Enzymatic semisynthesis of porcine despentapeptide (B26-30)insulin using unprotected desoctapeptide (B26–B30)insulin as a substrate. Int J Pept Protein Res 27:514–521
Kubiak T, Cowburn D (1986b) Trypsin-catalysed formation of pig des-(23–63)-proinsulin fromdesoctapeptide-(B23–30)-insulin. Biochem J 234:665–670
Kwok SCM, Steiner DF, Rubenstein AH, Tager HS (1983) Identification of a point mutation in the human insulin gene giving rise to a structurally abnormal insulin (insulin Chicago). Diabetes 32:872–875
Li CH, Yamashiro D, Gospodarowicz D, Kaplan SL, van Vliet G (1983) Total synthesis of insulin-like growth factor I (somatomedin C). Proc Natl Acad Sci USA 80:2216–2220
Linde S, Welinder BS, Hansen B, Sonne O (1986) Preparative reversed-phase high-performance liquid chromatography of iodinated insulin retaining full biological activity. J Chromatogr 369:327–339
Lloyd LF, Calam DH (1982) Separation of human insulin and some structural isomers by high-performance liquid chromatography. J Chromatogr 237:511–514
Lloyd LF, Corran PH (1982) Analysis of insulin preparations by reversed-phase high-performance liquid chromatography. J Chromatogr 240:445–454
Losse G, Raddatz H (1987) Synthese von B1-substituierten Peptidyl-Insulinen. J Prakt Chem 329:1–9
Losse G, Richter B, Naumann W, Mätzler G (1982) Neue bifunktionelle Brückenfunktionen zur A1–B29-Verklammerung der beiden Insulinketten. J Prakt Chem 324:993–1004
Lougheed WD, Albisser AM, Martindale HM, Chow JC, Clement JR (1983) Physical stability of insulin formulations. Diabetes 32:424–432
Markussen J (1985) Comparative reduction/oxidation studies with single chain des-(B30) insulin and porcine proinsulin. Int J Pept Protein Res 25:431–434
Markussen J (1987) Human insulin by tryptic transpeptidation of porcine insulin and biosynthetic precursors. MTP, Lancaster
Markussen J, Jørgensen KH, Sørensen AR, Thim L (1985) Single chain des-(B30)insulin. Int J Pept Protein Res 26:70–77
Markussen J, Diers I, Engesgaard A, Hansen MT, Hougaard P, Langkjaer L, Noms K, Ribel U, Sørensen AR, Søerensen E, Voigt HO (1987a) Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27, and B30. Protein Engineering 1:215–223
Markussen J, Hougaard P, Ribel U, Sorensen AR, Sørensen E (1987b) Soluble, prolonged-acting insulin derivatives. I. Degree of protraction and crystallizability of insulins substituted in the termini of the B-chain. Protein Engineering 1:205–213
Markussen J, Diers I, Hougaard P, Langkjaer L, Noms K, Snel L, Sørensen AR, Sørensen E, Voigt HO (1988) Soluble, prolonged-acting insulin derivatives. III. Degree of protaction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27, and B30. Protein Engineering 2:157–166
Marsh JW, Nahum A, Steiner DF (1983) Reductive methylation of insulin. Int J Pept Protein Res 22:39–49
Massague J, Czech MP (1985) Affinity cross-linking of receptors for insulin and the insulin-like growth factors I and II. Methods Enzymol 109:179–187
McLeod A, Wood SP (1984) High-performance liquid chromatography of insulin. J Chromatogr 285:319–331
Meienhofer J, Schnabel E, Bremer H, Brinkhoff O, Zabel R, Sroka W, Klostermeyer H, Brandenburg D, Okuda T, Zahn H (1963) Synthese der Insulinketten und ihre Kombination zu insulinaktiven Präparaten. Z Naturforsch 18B: 1120–1121
Misbin RI, Almira EC, Buynitzky SJ (1983) Insulin metabolism in rat hepatocytes. J Biol Chem 258:2157–2162
Morihara K, Ueno Y, Sakina K (1986) Influence of temperature in the enzymic semi-synthesis of human insulin by coupling and transpeptidation methods. Biochem J 240:803–810
Muir A, Offord RE, Davies JG (1986) The identification of a major product of the degradation of insulin by “insulin proteinase” (EC 3.4.22.11). Biochem J 237:631–637
Naithani VK, Gattner H-G (1982) Preparation and properties of citraconylinsulins. Hoppe-Seyler’s Z Physiol Chem 363:1443–1448
Naithani VK, Zahn H (1984) Synthesis of proinsulin. In: Hearn MTW (ed) Peptide and protein reviews, vol 3. Dekker, New York, pp 81–146
Nakagawa SH, Tager HS (1986) Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. J Biol Chem 261:7332–7341
Nakagawa SH, Tager HS (1987) Role of the COOH-terminal B-chain domain in insulin-receptor interactions. J Biol Chem 262:12054–12058
Nanjo K, Sänke T, Miyano M, Okai K, Sowa R, Kondo M, Nishimura S, Iwo K, Miyamura K, Given BD, Chan SJ, Tager HS, Steiner DF, Rubenstein AH (1986) Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3]insulin. J Clin Invest 77:514–519
Ng DS, Yip CC (1985) Peptide mapping of the insulin-binding site of the 130-kDa subunit of the insulin receptor by means of a novel cleavable radioactive photoprobe. Biochem Biophys Res Commun 133:154–160
Obermeier R, Seipke G (1984) Enzyme-catalyzed semisyntheses with porcine insulin. Process Biochem 19:29–32
Offord RE (1980) Semisynthetic proteins. Wiley, Chichester New York Brisbane
Ogawa H, Burke GT, Katsoyannis PG (1984) Synthesis and biological evaluation of a modified insulin incorporating the COOH-terminal hexapeptide (“D-region”) of insulin-like growth factor IL J Protein Chem 3:327–348
Ogawa H, Burke GT, Chanley JD, Katsoyannis PG (1987) Effect of N-methylation of selected peptide bonds on the biological activity of insulin. Int J Pept Protein Res 30:460–473
Otha N, Burke GT, Katsoyannis PG (1988) Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-Tryptophan-A]insulin. J Protein Chem 7:55–65
Pang DT, Shafer JA (1983) Stoichiometry for the binding of insulin to insulin receptors in adipocyte membranes. J Biol Chem 258:2514–2518
Petersen K-G, Schlüter KJ, Kerp L (eds) (1982) Neue Insuline. 1. Internationales Symposium, 4.-5. Dezember 1981, Freiburg
Pongor S, Brownlee M, Cerami A (1983) Preparation of high-potency, non-aggregating insulins using a novel sulfation procedure. Diabetes 32:1087–1091
Riemen MW, Pon LA, Carpenter FH (1983) Preparation of semisynthetic insulin analogues from bis(tert-butyl-oxycarbonyl)-desoctapeptide-insulin phenylhydrazide: importance of the aromatic region B24-B26. Biochemistry 22:1507–1515
Riemen MW, Hosoume JT, Hillyard NA, Allen MP, Carpenter FH (1985) Semisynthetic insulin analogs: substitution for Gly-B23 significantly alters the activity of destetrapeptide-insulin. In: Deber CM, Hruby VJ, Kopple KD (eds) Peptides 1985. Pierce Chem Comp, Rockford, pp 699–702
Rivier J, McClintock R (1983) Reversed-phase high-performance liquid chromatography of insulins from different species. J Chromatogr 268:112–119
Rose K, De Pury H, Offord RE (1983) Rapid preparation of human insulin and insulin analogues in high yield by enzyme-assisted semi-synthesis. Biochem J 211:671–676
Rose K, Gladstone J, Offord RE (1984a) A mass-spectrometric investigation of the mechanism of the semisynthetic transformation of pig insulin into an ester of insulin of human sequence. Biochem J 220:189–196
Rose K, Pochon S, Offord R (1984b) Oxygen-18 labeled human insulin: semisynthesis and mass-spectrometric analysis. In: Ragnarsson U (ed) Peptides 1984. Almqvist and Wik-sell, Stockhohn, pp 235–238
Roth RA, Maddux B (1983) Insulin-cholera toxin binding unit conjugate: a hybrid molecule with insulin biological activity and cholera toxin binding specificity. J Cell Physiol 115:151–158
Roth RA, Iwamoto Y, Maddux B, Golfine ID (1983) Insulin-ricin B chain conjugate has enhanced biological activity in insulin-insensitive cells. Endocrinology 112:2193–2199
Sakina K, Ueno Y, Oka T, Morihara K (1986) Enzymatic semisynthesis of [Leu B30]insulin. Int J Pept Protein Res 28:411–19
Sakura H, Iwamoto Y, Sakamoto Y, Kuzuya T, Hirata H (1986) Structurally abnormal insulin in a diabetic patient — characterization of the mutant insulin A3 (Val → Leu) isolated from the pancreas. J Clin Invest 78:1666–1672
Sato S, Ebert CD, Kim SW (1983) Prevention of insulin self-association and surface adsorption. J Pharm Sci 72:228–232
Saunders D, Freude K (1982) Cross-linked [D-AlaA1]insulins. Evidence for a change in the conformation of the insulin monomer at its receptor. Hoppe Seyler’s Z Physiol Chem 363:655–659
Saunders DJ, Brandenburg D (1984) Photoactivatable insulins and receptor photoaffmity labelling. In: Larner J, Pohl S (eds) Methods in diabetes research, vol I: laboratory methods, pt A. Wiley, New York, pp 3–22
Schartmann B, Gattner H-G, Danho W, Zahn H (1983) Erhöhte Insulinausbeuten durch “Recycling” der nichtkombinierten Ketten. Hoppe-Seyler’s Z Physiol Chem 364:179–186
Schüttler A, Brandenburg D (1982) Preparation and properties of covalently linked insulin dimers. Hoppe Seyler’s Z Physiol Chem 363:317–330
Schüttler A, Gattner H-G, Brandenburg D (1984) Preparation of selected insulin derivatives and analogues. In: Larner J, Pohl S (eds) Methods in diabetes research, vol I: Laboratory methods, pt A. Wiley, New York, pp 355–376
Schwartz G, Burke GT, Katsoyannis PG (1982) The importance of the B10 amino acid residue to the biological activity of insulin. [Lys10-B] Human insulin. J Protein Chem 1:177–189
Schwartz GP, Burke GT, Chanley JD, Katsoyannis PG (1983) An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin. Biochemistry 22:4561–4567
Schwartz GP, Wong D, Burke GT, De Vroede MA, Rechler MM, Katsoyannis PG (1985) Glutamine B16 insulin: reduced insulin-like metabolic activity with moderately preserved mitogenic activity. J Protein Chem 4:185–197
Schwartz GP, Burke GT, Katsoyannis PG (1987) A superactive insulin: [B10-Aspartic acid]insulin (human). Proc Natl Acad Sci USA 84:6408–6411
Seino S, Steiner DF, Bell GI (1987) Sequence of a New World primate insulin having low biological potency and immunoreactivity. Proc Natl Acad Sci USA 84:7423–7427
Selam J-L, Zirinis P, Mellet M, Mirouze J (1987) Stable insulin for implantable delivery systems: in vitro studies with different containers and solvents. Diabetes Care 10:343–347
Shoelson S, Fickova M, Haneda M, Nahum A, Musso G, Kaiser ET, Rubenstein AH, Tager H (1983a) Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. Proc Natl Acad Sci USA 80:7390–7394
Shoelson S, Haneda M, Blix P, Nanjo A, Sanke T, Inouye K, Steiner D, Rubenstein A, Tager H (1983b) Three mutant insulins in man. Nature 302:540–543
Sodoyez JC, Sodoyez-Goffaux F, Guillaume M, Merchie G (1983) [123I]Insulin metabolism in normal rats and humans: external detection by a scintillation camera. Science 219:865–867
Sonne O (1987) Receptor-mediated degradation of insulin in isolated rat adipocytes. Formation of a degradation product slightly smaller than insulin. Biochim Biophys Acta 927:106–111
Sonne O, Linde S, Larsen TR, Gliemann J, Larso L (1983) Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. Hoppe Seyler’s Z Physiol Chem 364:101–110
Srinivasa BR, Carpenter FH (1983) Intramolecular cross-linking of insulin. Int J Pept Protein Res 22:214–222
Stoev S, Zakhariev S, Golovinsky E, Gattner H-G, Naithani VK, Wollmer A, Brandenburg D (1988) Synthesis and properties of [A19-(p-fluorophenylalanine)] insulin. Biol Chem Hoppe-Seyler 369:1307–1315
Tatnell MA, Jones RH, Willey KP, Schüttler A, Brandenburg D (1983) Evidence concerning the mechanism of insulin-receptor interaction and the structure of the insulin receptor from biological properties of covalently linked insulin dimers. Biochem J 216:687–694
Thim L, Hansen MT, Norris K, Hoegh I, Boel E, Forstrom J, Ammerer G, Fiil NP (1986) Secretion and processing of insulin precursors in yeast. Proc Natl Acad Sci USA 83:6766–6770
Tian Y, Wang C-C, Tsou C-L (1987) Interaction and combination of separate A and B chains of insulin. Effects of D-and L-tryptophan in position A1. Biol Chem Hoppe-Seyler’s 368:397–403
Trindler P, Brandenburg D (1982) Semisynthetic modification of the N-terminus of the insulin A-chain. In: Voelter W, Wünsch E, Ovchinnikov Yu, Ivanov V (eds) Chemistry of peptides and proteins, vol 1. De Gruyter, New York, pp 307–314
Varley JM, Davies JG, Shire D, Offord RE, Tirnmis KN (1988) Engineered rat I insulin analogue having a B16Tyr/Asp replacement exhibits unchanged susceptibility to cleavage by insulin proteinase. Eur J Biochem 171:351–354
Vigh Gy, Varga-Puchony Z, Szepesi G, Gazdag M (1987) Semi-preparative high-performance reversed-phase displacement chromatography of insulins. J Chromatogr 386:353–362
Wang C-C, Tsou C-L (1986) Interaction and reconstitution of carboxyl-terminal-shortened B chains with the intact A chain of insulin. Biochemistry 25:5336–5340
Wedekind F, Baer-Pontzen K, Bala-Mohan S, Choli D, Zahn H, Brandenburg D (1989) Hormone binding site of the insulin receptor: analysis using photoaffinity-mediated avidin complexing. Biol Chem Hoppe-Seyler 370:251–258
Welinder BS, Linde S, Hansen B (1984) Isolation of specific labeled insulin tracers. Comparison between RP-HPLC and disc electrophoresis — ion exchange chromatography. In: Larner J, Pohl S (eds) Methods in diabetes res, vol 1: laboratory methods, pt B. Wiley, New York, pp 341–354
Wieneke H-J, Wolf G, Wolff W, Büllesbach EE, Gattner H-G, Brandenburg D (1983a) Synthesis of a hybrid chicken/human insulin. In: Bláha K, Maloň P (eds) Peptides 1982. De Gruyter, New York, pp 367–370
Wieneke H-J, Danho W, Büllesbach EE, Gattner H-G, Zahn H (1983b) The synthesis of [A19-3-iodotyrosine] and [A19–3, 5-diiodotyrosine]-insulin (porcine). Hoppe-Seyler’s Z Physiol Chem 364:537–550
Yip CC, Yeung CWT (1985) Photoaffmity labelling of the insulin receptor. Methods En-zymol 109:170–179
Zahn H (1983) Insulin: Von der Strukturaufklärung zur chemischen Synthese. Münch Med Wochenschr 125 [Suppl 1]:3–13
Zaitsu K, Hosoya H, Hayashi Y, Yamada H, Ohkura Y (1985) High-performance liquid Chromatographic separation of citraconylinsulins and preparation of GlyA1PheB1-dicitraconylinsulin. Chem Pharm Bull 33:1159–1163
Zhang Y-S, Cao Q-P, Li Z-G, Cui D-F (1983) Preparation of [B23-D-alanine]des-(B25–B30)-hexapeptide-insulin by a combination of enzymic and non-enzymic synthesis. Biochem J 215:697–699
Zhu S-Q (1985) Studies on structure and biological activity of insulin. In: Molecular architecture of proteins and enzymes. Academic Press, New York, pp 185-197
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Brandenburg, D. (1990). Insulin Chemistry. In: Cuatrecasas, P., Jacobs, S. (eds) Insulin. Handbook of Experimental Pharmacology, vol 92. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74098-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-74098-5_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74100-5
Online ISBN: 978-3-642-74098-5
eBook Packages: Springer Book Archive